Cogent Biosciences Inc (COGT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.97B
Last updated: Nov 17, 2026 at 4:20 PM ET
Cogent Biosciences Inc (COGT) Stock Chart
Cogent Biosciences (COGT) has a latest price of $27.85 on Nov 17, 2026, 36.3% below its 52-week high of $43.73. Its price fell 17.0% over the past 12 months. The month-end price fell 30.2% since Mar 2018, a compound annual decline of 4.1%.
Price Chart
From Mar 2018 to Oct 2026, its highest month-end close was $67.08 in Jul 2018 and its lowest $1.65 in Mar 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart COGT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for COGT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 24.4%, and over 6 months it fell 10.9%. The month-end price rose 280.1% over the 3 years through Oct 2026, a compound annual rate of 56.1%.
| Period | Change |
|---|---|
| 1 month | -7.2% |
| 3 months | -24.4% |
| 6 months | -10.9% |
| 12 months | -17.0% |
| 12 months, with dividends | -17.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +280.1% | +56.1% |
| 5 years | +265.8% | +29.6% |
| Since Mar 2018 | -30.2% | -4.1% |
Price by Year
Its best calendar year was 2025, when the price rose 355.4%, and its weakest was 2019, when it fell 83.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $31.02 | -12.7% |
| 2025 | $35.52 | +355.4% |
| 2024 | $7.80 | +32.7% |
| 2023 | $5.88 | -49.1% |
| 2022 | $11.56 | +34.7% |
| 2021 | $8.58 | -23.6% |
| 2020 | $11.23 | +289.9% |
| 2019 | $2.88 | -83.6% |
Trading Range
The price is 10.4% below its 50-day average of $31.10 and 20.9% below its 200-day average of $35.21.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $27.85 | |
| 52-week high | $43.73 | -36.3% |
| 52-week low | $27.23 | +2.3% |
| 50-day average | $31.10 | -10.4% |
| 200-day average | $35.21 | -20.9% |
Price Risk
Over 3 years, its largest fall from a peak was 67.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.36 |
| Largest fall, 1 year | -35.9% |
| Largest fall, 3 years | -67.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About COGT
What is COGT's 1-year price change?
Cogent Biosciences's price fell 17.0% over the past 12 months. With dividends included, the 12-month total return was -17.0%.
What is COGT's 5-year price change?
Cogent Biosciences's month-end price rose 265.8% over the 5 years through Oct 2026, a compound annual rate of 29.6%. These figures leave out dividends.
What is COGT's 52-week high and low?
Cogent Biosciences's 52-week high is $43.73 and its 52-week low is $27.23. Its latest price of $27.85 on Nov 17, 2026 is 36.3% below the high.
What is COGT's beta?
Cogent Biosciences's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 35.9%.
Is the COGT chart free?
Yes. Advanced Charting for COGT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
COGT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors